Combined interventional therapies of hepatocellular carcinoma. - Wikidata - awgldk - TriplyDB

Combined interventional therapies of hepatocellular carcinoma.

Combined interventional therapies of hepatocellular carcinoma.

http://www.wikidata.org/entity/Q31156779

about

Transarterial administration of integrin inhibitor loaded nanoparticles combined with transarterial chemoembolization for treating hepatocellular carcinoma in a rat model BCRP/ABCG2 inhibition sensitizes hepatocellular carcinoma cells to sorafenib Gold(III) compound is a novel chemocytotoxic agent for hepatocellular carcinoma Role of transarterial chemoembolization for hepatocellular carcinoma before liver transplantation with special consideration of tumor necrosis.Hepatocellular carcinoma treated with interventional procedures: CT and MRI follow-up Computed tomography-guided transpulmonary radiofrequency ablation for hepatocellular carcinoma located in hepatic dome Anticancer and cytotoxic properties of the latex of Calotropis procera in a transgenic mouse model of hepatocellular carcinoma.Chemokine expression in hepatocellular carcinoma versus colorectal liver metastases.Ultrasound-guided percutaneous laser and ethanol ablation of rabbit VX2 liver tumors.p53 gene therapy in combination with transcatheter arterial chemoembolization for HCC: one-year follow-up Radiofrequency ablation versus hepatic resection for the treatment of early-stage hepatocellular carcinoma meeting Milan criteria: a systematic review and meta-analysis.Stereotactic body radiation therapy for hepatocellular carcinoma: prognostic factors of local control, overall survival, and toxicity Efficacy and safety of radiofrequency ablation and transcatheter arterial chemoembolization for treatment of hepatocellular carcinoma: A meta-analysis.Local recurrence is an important prognostic factor of hepatocellular carcinoma.Branched-chain amino acid treatment before transcatheter arterial chemoembolization for hepatocellular carcinoma.Transarterial chemoembolization of hepatocellular carcinoma in a rat model: the effect of additional injection of survivin siRNA to the treatment protocol Potential involvement of leptin in carcinogenesis of hepatocellular carcinoma Safety of Curcuma aromatica oil gelatin microspheres administered via hepatic artery.Endostatin gene therapy for liver cancer by a recombinant adenovirus delivery Gender difference in clinicopathologic features and survival of patients with hepatocellular carcinoma.Therapeutic effects and prognostic factors in three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for hepatocellular carcinoma Radiotherapy for 65 patients with advanced unresectable hepatocellular carcinoma.Chinese herb related molecules of cancer-cell-apoptosis: a minireview of progress between Kanglaite injection and related genes Hypoxia-activated cytotoxic agent tirapazamine enhances hepatic artery ligation-induced killing of liver tumor in HBx transgenic mice.131I-labeled metuximab combined with chemoembolization for unresectable hepatocellular carcinoma.Iodized oil uptake assessment with cone-beam CT in chemoembolization of small hepatocellular carcinomas.Outcome of transarterial chemoembolization monotherapy, and in combination with percutaneous ethanol injection, or radiofrequency ablation therapy for hepatocellular carcinoma.Study on the effect of chemoembolization combined with microwave ablation for the treatment of hepatocellular carcinoma in rats.Meta-analysis of transcatheter arterial chemoembolization plus radiofrequency ablation versus transcatheter arterial chemoembolization alone for hepatocellular carcinoma Promising therapeutic efficacy of a novel REIC/Dkk-3 expressing adenoviral vector for hepatocellular carcinoma.Association of hepatic vein Lipiodol tram-track sign during transcatheter arterial chemoembolization with perioperative death.Percutaneous radiofrequency ablation of hepatocellular carcinoma in cirrhosis: analysis of complications in a single centre over 20 years.Assessment of supra-additive effects of cytotoxic drugs and low dose rate irradiation in an in vitro model for hepatocellular carcinoma.Combined ethanol injection therapy and radiofrequency ablation therapy in percutaneous treatment of hepatocellular carcinoma larger than 4 cm.Glycyrrhetinic acid-functionalized mesoporous silica nanoparticles as hepatocellular carcinoma-targeted drug carrier.Combined transarterial chemoembolization and arterial administration of Bletilla striata in treatment of liver tumor in rats.Primary targeting of recombinant Fv-immunotoxin hscFv(25)-mTNFalpha against hepatocellular carcinoma.Gene therapy of liver cancer.Expression of transforming growth factor-alpha and hepatitis B surface antigen in human hepatocellular carcinoma tissues and its significance.Experimental study on transarterial administration of GRGDSP combined with transarterial chemoembolization in rats with hepatic carcinoma.

P2860

Q24658607-772B0371-E550-41AD-8DD7-F3DDBF92E223 Q28538126-3F2BA5A2-D2EE-4A6E-B5ED-D15B9277AF99 Q28580848-51EDB184-5AC1-481F-BA47-D47453593119 Q30905155-86930CFD-C85A-470F-86F8-E6C8619DA349 Q33208819-0CBDAE2A-4576-4FFA-B4F4-0D5356870876 Q33788341-F7F54815-66E5-485B-A42A-FAC18828141C Q33868476-439B13C0-FC5D-4675-B8EC-6494B52DE7EE Q34017734-F1C94778-BD4C-472E-96BE-118C4680ED18 Q34617807-43156A19-2DDE-43B4-94A2-3FF0A69CBD67 Q34884726-4B6B16EE-4CA8-4CF7-AFBA-188C67C3FA37 Q34939487-9B0C16FC-02F3-4EDE-8456-AE7351176CAD Q35023155-CE2A1F93-8CB9-47C7-9FB6-6B68A932C1AF Q35743221-9333A231-C90E-44C5-8C1E-EE31CAED994E Q35784062-F1F2B4E8-4A6F-4821-8CA7-230D30B54358 Q35872118-DAD9BE76-519E-46DE-AA78-9666E4620844 Q36027056-1E27308B-CD99-4D1E-905B-2560EA03A711 Q36065676-30957B5A-740D-46AB-A337-2DACDEBE16CD Q36065776-434E100B-32DB-4E51-9B16-A76F8F27E86D Q36065853-AA3D518A-4FB3-43D3-8B0E-4564A1794159 Q36067465-53A3DE5F-20E4-4B81-AC35-90A73902C4FD Q36496500-00D007D1-9BFC-4AD3-A193-AEFBBB198290 Q37248755-DC3587E8-C5FD-4D41-8598-609AB18DD19D Q37248816-F89052BF-FB60-4CAD-A8F1-B4AD1656EF1B Q37369324-863A8C51-B6AC-461C-80A9-3821CA465720 Q37408971-B8E538D2-F3AC-4F01-B273-5F55CFF0CCA2 Q37468468-888478A9-C0FB-414C-A28A-F932A9E806EA Q37519923-693C53F5-B60B-4CCD-B375-A38C961B3582 Q37682471-9C70DD03-9430-4C17-BEBE-80267607E46A Q37709406-AFCBD258-4C3E-40E5-9CBE-CE9B65E9E1F3 Q38717563-17726A15-4E08-4BB0-9F95-C4462D1406FD Q38829063-CCC1EEA3-469A-4B73-B203-85B64CDA0836 Q39237369-2F911F89-5B55-4A58-A3DB-08F3BAD3D6C1 Q40183947-E24315AA-366A-440D-A1C7-1D49DD0B0ED5 Q40484234-26F6BB83-E144-41A1-BC92-A5B579A60F64 Q41095468-04E03956-5AF9-4273-B5A9-A84F04B27C34 Q41771459-FB3BF054-AF8B-40F1-AC2C-24EBB2070194 Q41886208-5520B918-71D6-4321-A414-8F0D078734FA Q42726362-7F6DBBBB-FEC4-4CEA-B28F-4F3469833A52 Q43058499-13873080-C7D8-4128-80B6-B722F8DBCD16 Q46867166-92F009B3-FEEF-4CD3-AD47-377059DACC5C

P2860

Combined interventional therapies of hepatocellular carcinoma.

http://www.wikidata.org/entity/Q31156779

description

2003 nî lūn-bûn

@nan

2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

name

Combined interventional therapies of hepatocellular carcinoma.

@ast

Combined interventional therapies of hepatocellular carcinoma.

@en

type

label

Combined interventional therapies of hepatocellular carcinoma.

@ast

Combined interventional therapies of hepatocellular carcinoma.

@en

prefLabel

Combined interventional therapies of hepatocellular carcinoma.

@ast

Combined interventional therapies of hepatocellular carcinoma.

@en

P1433

Q31156779-ED314359-51A6-4F54-BE01-3E6270E14686

P1476

Q31156779-BD6D6FCB-1FBE-418C-8B90-3923B68AABD0

P2093

Q31156779-56B45FB9-E433-4BA0-B7E9-6D8E53F63ABD

Q31156779-BCE0DD81-F615-46CB-A5DE-D5FDE2444C8C

Q31156779-E65A4FF2-637F-48C1-9BA4-9AD636171433

P2860

Q31156779-00297647-05EC-4BE5-8451-C8E21814F7CC

Q31156779-00BC9E3A-8293-4D31-B7C1-53529F524507

Q31156779-00E450CA-A940-4714-8241-24DD1680506F

Q31156779-02D1BA7C-186A-4F9C-9116-3C700D612D68

Q31156779-07047C30-C842-4ACF-84EE-93AD4C3A8310

Q31156779-0B1FA284-8F39-418F-AE66-EE761463A98A

Q31156779-0C80BD36-5B80-44C4-8496-92D87872E33D

Q31156779-1B691A1C-236A-4957-B6C8-25639BE1C52B

Q31156779-1FB9FAC7-A4ED-42C3-9F34-867220B5AB74

Q31156779-21F19CCC-ACD4-4F23-A9B2-0C3A5FA792C3

P304

Q31156779-D208B7BF-65E4-4EB9-81A1-B9FDCFEC4515

P31

Q31156779-999DDA5A-DECE-4A2F-8220-66C2267F3812

P356

Q31156779-CD8BBB19-0AEA-4E10-8579-25E04853AF5C

P407

Q31156779-0FCDEE60-9B4D-4BFE-8E63-534E6B04A31D

P433

Q31156779-21BD52EE-7466-438C-A4BE-A7B87EBC9C88

P478

Q31156779-F13B0906-B78F-41CA-B828-9B68B369D1AC

P577

Q31156779-4CA6BD2D-864D-4C27-8018-CEC91B3B277E

P5875

Q31156779-B162472D-AF8D-4651-89D7-5433E307C32C

P698

Q31156779-6AFB495D-8B24-4A4A-B257-66E489C997DA

P932

Q31156779-4A8A4D78-934E-442F-9BF5-FCFF0E399AD4

P356

P1433

World Journal of Gastroenterology

P1476

Combined interventional therapies of hepatocellular carcinoma.

@en

P2093

Gan-Sheng Feng

http://www.w3.org/2001/XMLSchema#string

Jun Qian

http://www.w3.org/2001/XMLSchema#string

Thomas Vogl

http://www.w3.org/2001/XMLSchema#string

P2860

Locoregional immuno(bio)therapy for liver metastases

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis.

[Percutaneous laser ablation of malignant liver tumors]

Hepatocellular carcinoma: long-term results of combined treatment with laser thermal ablation and transcatheter arterial chemoembolization.

Liver metastases: interventional therapeutic techniques and results, state of the art.

Laser thermal ablation in the treatment of small hepatocellular carcinoma: results in 74 patients.

Hepatocellular carcinoma: treatment with transcatheter arterial chemoembolization.

[Locally ablative therapies of hepatocellular carcinoma]

Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon's perspective.

P304

1885-1891

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V9.I9.1885

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2003-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

291416187

http://www.w3.org/2001/XMLSchema#string

P698

12970869

http://www.w3.org/2001/XMLSchema#string

P932

4656637

http://www.w3.org/2001/XMLSchema#string